NRC (NRC) Q4 2025: TRCV Climbs 8% as Enablement and Retention Drive Predictable Growth
NRC Health’s sequential TRCV growth and disciplined margin management signal a business model built for resilience and compounding value. The company’s operational realignment and enablement product momentum set up 2026 for a return to top-line growth, with retention and cross-sell emerging as durable levers. Investors should watch for how new leadership and AI-driven innovation translate into expanded customer adoption and deeper market penetration.
Summary
- TRCV Momentum Signals Underlying Health: Sustained contract value growth points to renewed sales and retention strength.
- Enablement Solutions Gain Traction: Workflow automation and integration drive new adoption and cross-sell opportunity.
- Leadership and Innovation Catalyze Next Phase: New executive hires and AI capabilities position NRC for broader market impact.
Business Overview
NRC Health provides software and data analytics solutions for healthcare organizations, enabling providers to capture, analyze, and act on patient, employee, and community feedback. The company generates revenue primarily through multi-year, recurring subscription contracts, with 99% of revenue classified as recurring. Major segments include experience solutions (patient and employee feedback), enablement solutions (workflow and operational tools), strategic insights (market and consumer analytics), and governance solutions (board and executive education).
Performance Analysis
Fourth quarter revenue was $35.2 million, down year-over-year but up sequentially, reflecting the tail-end impact of prior-year contract attrition and the beginnings of a recovery cycle. The company’s most telling metric, total recurring contract value (TRCV), grew 8% year-over-year and marked the fifth consecutive quarter of sequential improvement, underscoring the stickiness and forward visibility of NRC’s business model.
Adjusted EBITDA margins held near 30%, even as revenue contracted, demonstrating cost discipline and a scalable operating structure. The company paid a $0.12 per share dividend and continued opportunistic share repurchases, highlighting strong free cash flow conversion and a commitment to shareholder returns. Notably, full-year new sales surged 86%, and customer retention reached a seven-year high, both direct results of a sales force realignment and deeper customer engagement initiatives.
- Retention Inflection: Gross dollar retention hit its highest level in seven years, reflecting improved customer success execution.
- Enablement Expansion: Rounding, NRC’s workflow-driven enablement solution, nearly doubled TRCV in 2025, validating expansion beyond core experience products.
- Margin Durability: Despite lower revenue, NRC maintained strong EBITDA margins, positioning the business for leverage as growth returns.
Management’s confidence in future revenue growth is anchored in the visible TRCV pipeline and ongoing product innovation, with AI enhancements and new leadership expected to further accelerate adoption and cross-sell in 2026.
Executive Commentary
"This sustained momentum underscores the effectiveness of our go-to-market strategy and the strength of our value proposition as healthcare providers navigate an increasingly complex operating environment."
Trent Green, CEO
"Our adjusted EBITDA margin is currently near 30%, and we see upside as revenue recovers. As we execute on those six growth catalysts, we will ensure NRC is positioned well for margin expansion."
Shane Harrison, CFO
Strategic Positioning
1. Go-To-Market Realignment Yields Sales Acceleration
NRC restructured its sales organization to better mirror healthcare system decision-making, resulting in an 86% increase in new sales and improved engagement at multiple organizational levels. This approach is credited with driving larger, more strategic customer relationships and improving cross-sell potential.
2. Enablement Solutions as a Growth Engine
The integration and expansion of enablement solutions—workflow automation tools that operationalize feedback— have emerged as a major growth lever. The Rounding product, acquired just over a year ago, nearly doubled its TRCV in 2025, and management sees significant runway for similar solutions targeting operational improvement in quality, safety, and discharge planning.
3. Product Innovation and AI Integration
AI capabilities are being embedded across NRC’s platform, from sentiment analysis and comment summarization to real-time service recovery. The recent beta release of AI-powered listening within Rounding exemplifies NRC’s push to help clients move from insight to action faster, differentiating the offering in a crowded market.
4. Leadership Depth and Market Insights
The addition of David Burek, a healthcare consulting veteran, to lead strategic insights and governance, reflects NRC’s intent to blend industry expertise with SaaS execution. This leadership build-out is designed to accelerate both innovation and market penetration, especially in high-value board and executive engagement offerings.
5. Durable Retention and Cross-Sell Opportunity
Retention reached a multi-year high, and management sees further upside as customer success initiatives mature. With 74% of the top 100 health systems as clients, NRC is well-positioned to deepen wallet share through expanded adoption of enablement, insights, and governance products.
Key Considerations
NRC’s Q4 results highlight a business at an inflection point, with operational and product investments beginning to translate into measurable growth levers. The company’s model offers high revenue visibility, but the pace of revenue recovery will depend on continued execution in enablement and cross-sell, as well as the success of new leadership and innovation efforts.
Key Considerations:
- TRCV as a Leading Indicator: Investors should focus on TRCV trends as the most reliable signal of future revenue growth, given the lag between contract wins and revenue recognition.
- Enablement Product Adoption: The momentum in Rounding and adjacent workflow solutions will be critical for expanding NRC’s addressable market and diversifying revenue streams.
- Margin Expansion Potential: With cost discipline proven through the downturn, incremental revenue should drive outsized margin improvement as growth resumes.
- Leadership and Talent Depth: Recent executive hires bring domain expertise and may accelerate NRC’s penetration in strategic insights and governance, but execution risk remains during integration.
Risks
Revenue recovery is contingent on sustained TRCV growth converting into recognized revenue, and any slowdown in healthcare provider spending or competitive encroachment could blunt momentum. There is also execution risk as NRC integrates new leadership and continues to expand its product set, particularly in the fast-evolving AI landscape. Additionally, while retention is strong, a reversal in customer satisfaction or a failure to deliver measurable ROI could pressure future renewal rates.
Forward Outlook
For Q1 2026, NRC guided to:
- Sequential revenue growth as TRCV momentum flows into recognized revenue
- Continued investment in enablement and AI-driven product capabilities
For full-year 2026, management maintained its focus on:
- Revenue growth in line with TRCV gains
- Margin expansion as operating leverage returns
Management highlighted several factors that will shape the year ahead:
- Scaling enablement solutions beyond Rounding to new operational domains
- Leveraging new leadership to accelerate innovation and customer engagement
Takeaways
NRC enters 2026 with a solid foundation, a high-visibility revenue pipeline, and multiple levers for growth and margin expansion. The interplay between product innovation, enablement adoption, and retention will determine the pace and durability of the company’s return to top-line growth.
- Enablement and AI Are NRC’s Next Growth Frontier: Workflow automation and advanced analytics are driving deeper customer integration and new market opportunities.
- Retention and Cross-Sell Remain Durable Levers: Multi-year high retention and a broadened portfolio set up NRC for compounding customer value.
- Watch for New Logo and Product Adoption Traction: The impact of leadership changes and innovation investments will be visible in new customer wins and expanded solution uptake.
Conclusion
NRC’s Q4 and full-year 2025 results demonstrate the company’s ability to navigate a challenging revenue environment while building the foundation for renewed growth. With strong recurring revenue, disciplined cost management, and accelerating adoption of new solutions, NRC is positioned to benefit from secular trends in healthcare data, workflow automation, and governance.
Industry Read-Through
NRC’s results reinforce several key themes for the broader healthcare technology sector: Providers are prioritizing solutions that deliver measurable operational improvement, not just analytics. The shift toward enablement and workflow automation is accelerating, and vendors with deep domain expertise and trusted brands are best positioned to win. High retention and cross-sell in a recurring revenue model are critical for compounding value, especially as health systems face ongoing budget and complexity pressures. Finally, the integration of AI into feedback and workflow solutions is quickly becoming table stakes, raising the bar for differentiation and speed to value across the industry.